Deconstructing vancomycin

Science

Volumn 284, Issue 5413, 1999, Pages 442-443

  Walsh, Christopher ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

BACTERIAL CELL WALL; DRUG ACTIVITY; DRUG CONFORMATION; DRUG MECHANISM; ENTEROCOCCUS FAECALIS; GRAM POSITIVE BACTERIUM; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIA; CELL WALL; DIPEPTIDES; DISACCHARIDES; DRUG DESIGN; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; GLYCOSYLATION; HEXOSYLTRANSFERASES; HYDROGEN BONDING; PEPTIDOGLYCAN; PEPTIDOGLYCAN GLYCOSYLTRANSFERASE; STRUCTURE-ACTIVITY RELATIONSHIP; VANCOMYCIN;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 0033574766     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.284.5413.442     Document Type: Short Survey

References (10)

1. T. L. Smith et al., N. Engl. J. Med. 340, 493 (1999).
2. K. Sieradzki, R. B. Roberts, S.W. Haber, A. Tomasz, ibid., p. 517.
3. F. A. Waldvogel, ibid., p. 556.
4. M. Ge et al., Science 284, 508 (1999).
5. T. D. H. Bugg et al., Biochemistry 30, 10408 (1991).
6. C. T. Walsh, S. L. Fisher, I. S. Park, M. Prahalad, Z. Wu, Chem. Biol. 3, 21 (1996).
7. D. A. Evans et al., Angew. Chem. Int. Ed. 37, 2700 (1998).
8. K. C. Nicolaou et al., ibid., p. 2717.
9. C. Thompson, M. Ge, D. Kahne, J. Am. Chem. Soc. 121, 1237 (1999).
10. See D. H. Williams, Nat. Prod. Rep. 13, 469 (1996).